A detailed history of Archetype Wealth Partners transactions in Merck & Co., Inc. stock. As of the latest transaction made, Archetype Wealth Partners holds 4,033 shares of MRK stock, worth $401,081. This represents 0.07% of its overall portfolio holdings.

Number of Shares
4,033
Previous 4,340 7.07%
Holding current value
$401,081
Previous $537,000 14.71%
% of portfolio
0.07%
Previous 0.09%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$111.15 - $128.97 $34,123 - $39,593
-307 Reduced 7.07%
4,033 $458,000
Q1 2024

May 14, 2024

SELL
$113.24 - $131.95 $57,412 - $66,898
-507 Reduced 10.46%
4,340 $573,000
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $22,239 - $24,202
222 Added 4.8%
4,847 $528,000
Q3 2023

Nov 13, 2023

BUY
$102.95 - $114.33 $9,780 - $10,861
95 Added 2.1%
4,625 $476,000
Q2 2023

Aug 14, 2023

BUY
$108.61 - $118.38 $25,740 - $28,056
237 Added 5.52%
4,530 $523,000
Q1 2023

May 10, 2023

BUY
$102.94 - $114.86 $45,087 - $50,308
438 Added 11.36%
4,293 $457,000
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $34,888 - $44,731
399 Added 11.55%
3,855 $428,000
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $100,168 - $112,527
-1,185 Reduced 25.53%
3,456 $298,000
Q2 2022

Aug 15, 2022

BUY
$83.49 - $94.64 $98,935 - $112,148
1,185 Added 34.29%
4,641 $423,000
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $2,891 - $3,621
40 Added 1.17%
3,456 $265,000
Q2 2021

Aug 13, 2021

BUY
$70.31 - $77.77 $40,850 - $45,184
581 Added 20.49%
3,416 $266,000
Q1 2021

Apr 30, 2021

BUY
$68.86 - $81.11 $1,308 - $1,541
19 Added 0.67%
2,835 $219,000
Q3 2020

Oct 15, 2020

SELL
$73.18 - $82.95 $6,220 - $7,050
-85 Reduced 2.93%
2,816 $234,000
Q2 2020

Aug 13, 2020

BUY
$70.42 - $80.13 $204,288 - $232,457
2,901 New
2,901 $224,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Archetype Wealth Partners Portfolio

Follow Archetype Wealth Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Archetype Wealth Partners, based on Form 13F filings with the SEC.

News

Stay updated on Archetype Wealth Partners with notifications on news.